Brief: Quotient Ltd Announces Sars-Cov-2 (Covid-19) Antibody Test Final Performance Data
27/04/2020 21:12
April 27 (Reuters) - Quotient Ltd QTNT.O :
* QUOTIENT LIMITED ANNOUNCES SARS-COV-2 (COVID-19) ANTIBODY
TEST
FINAL PERFORMANCE DATA
* QUOTIENT -EXPECTS TO COMPLETE CE MARKING PROCESS,
SUBMISSION OF
FDA EMERGENCY USE AUTHORIZATION FOR MOSAIQ COVID-19 ANTIBODY
MICROARRAY IN A FEW DAYS
Source text for Eikon: ID:nGNX22C6nf
Further company coverage: QTNT.O
((Briefs@thomsonreuters.com;))
Recent news on Quotient
See all newsBrief: Quotient Ltd Enters Into Amended And Restated Transaction Support Agreement
U.S. STOCKS ON THE MOVE-Tesla, Exxon Mobil, Chevron
Quotient down on plans to delist from Nasdaq
Brief: Quotient Limited Announces Intent To Voluntary Delist From The Nasdaq Global Market
U.S. STOCKS ON THE MOVE-Organon, Veracyte, InfuSystem